PRNewsWire - Health

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
CCA Industries, Inc. Reports Results of Operations for the Quarter ended February 28, 2025
Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight
Vantage Foundation besucht SOS-Kinderdorf Portugal: Vernachlässigung bekämpfen und den Kreislauf durchbrechen